Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-085889
Filing Date
2024-08-05
Accepted
2024-08-05 17:00:55
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 tm2420753-1_s3.htm S-3 280747
2 EXHIBIT 2.1 tm2420753d2_ex2-1.htm EX-2.1 180422
3 EXHIBIT 23.2 tm2420753d2_ex23-2.htm EX-23.2 2616
4 EX-FILING FEES tm2420753d2_ex-filingfees.htm EX-FILING FEES 20949
5 GRAPHIC bc_exemplary-4clr.jpg GRAPHIC 107272
6 GRAPHIC bc_partcst-4clr.jpg GRAPHIC 85657
7 GRAPHIC lc_primary-4clr.jpg GRAPHIC 77556
8 GRAPHIC lg_rezolute-4clr.jpg GRAPHIC 8231
9 GRAPHIC tb_treatment-4clr.jpg GRAPHIC 113334
10 GRAPHIC tm2420753d1_ex23-2img003.jpg GRAPHIC 26910
11 GRAPHIC tm2420753d1_ex23-2img004.jpg GRAPHIC 4878
  Complete submission text file 0001104659-24-085889.txt   1065906
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: S-3 | Act: 33 | File No.: 333-281257 | Film No.: 241175811
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)